Market Cap 25.97M
Revenue (ttm) 0.00
Net Income (ttm) -65.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 117,100
Avg Vol 85,984
Day's Range N/A - N/A
Shares Out 22.39M
Stochastic %K 71%
Beta -1.22
Analysts Sell
Price Target $3.50

Company Profile

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 dem...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 766 9912
Address:
10955 Alexandria Way, Suite 100, San Diego, United States
NVDAMillionaire
NVDAMillionaire Sep. 9 at 12:24 PM
$BOLD Really good write-up that perfectly summarizes BOLD's present situation. So if you want to bring your BOLD knowledge up to date or just discover BOLD, this is required reading. https://beyondspx.com/quote/BOLD/analysis/unlocking-cancer-s-code-boundless-bio-s-ecdna-strategy-and-extended-runway-bold
0 · Reply
MorenitaScorp
MorenitaScorp Sep. 2 at 12:43 PM
$BOLD ⌚️
0 · Reply
topstockalerts
topstockalerts Sep. 2 at 11:03 AM
Pre Market Top Gainers PT2 $MLYS $FLGC $BOLD $TIXT $CYCU
0 · Reply
habesha_kingtchalla
habesha_kingtchalla Aug. 28 at 2:01 AM
0 · Reply
ZenithZephyr
ZenithZephyr Aug. 23 at 7:50 AM
$BOLD Boundless Bio Inc is a clinical stage oncology company with novel target approach
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 11:00 AM
HC Wainwright & Co. has adjusted their stance on Boundless Bio ( $BOLD ), setting the rating to Buy with a target price of 5 → 4.
0 · Reply
Galtor
Galtor Jul. 29 at 11:08 PM
$BOLD how is this not pulling a $BHVN type run like they had a couple years ago??
0 · Reply
Galtor
Galtor Jul. 23 at 11:38 PM
$BOLD now begins the steady climb up
0 · Reply
Dirk1969
Dirk1969 Jul. 19 at 6:26 AM
$BOLD https://www.fiercebiotech.com/biotech/boundless-bio-lays-33-staff-lead-program-stumbles
1 · Reply
soopabox
soopabox Jul. 18 at 2:41 PM
$BOLD On the 3 month chart a very vague handle of a cup and handle seems to be forming. It looks more like a skillet instead of a cup. Not getting excited about it until -or- if it breaks 1.20 with volume.
1 · Reply
Latest News on BOLD
Boundless Bio Announces Pipeline and Leadership Updates

Dec 12, 2024, 4:01 PM EST - 9 months ago

Boundless Bio Announces Pipeline and Leadership Updates


Boundless Bio Announces Pricing of Initial Public Offering

Mar 27, 2024, 6:55 PM EDT - 1 year ago

Boundless Bio Announces Pricing of Initial Public Offering


Boundless Bio Starts $100 Million U.S. IPO Plan

Mar 12, 2024, 4:16 PM EDT - 1 year ago

Boundless Bio Starts $100 Million U.S. IPO Plan


NVDAMillionaire
NVDAMillionaire Sep. 9 at 12:24 PM
$BOLD Really good write-up that perfectly summarizes BOLD's present situation. So if you want to bring your BOLD knowledge up to date or just discover BOLD, this is required reading. https://beyondspx.com/quote/BOLD/analysis/unlocking-cancer-s-code-boundless-bio-s-ecdna-strategy-and-extended-runway-bold
0 · Reply
MorenitaScorp
MorenitaScorp Sep. 2 at 12:43 PM
$BOLD ⌚️
0 · Reply
topstockalerts
topstockalerts Sep. 2 at 11:03 AM
Pre Market Top Gainers PT2 $MLYS $FLGC $BOLD $TIXT $CYCU
0 · Reply
habesha_kingtchalla
habesha_kingtchalla Aug. 28 at 2:01 AM
0 · Reply
ZenithZephyr
ZenithZephyr Aug. 23 at 7:50 AM
$BOLD Boundless Bio Inc is a clinical stage oncology company with novel target approach
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 11:00 AM
HC Wainwright & Co. has adjusted their stance on Boundless Bio ( $BOLD ), setting the rating to Buy with a target price of 5 → 4.
0 · Reply
Galtor
Galtor Jul. 29 at 11:08 PM
$BOLD how is this not pulling a $BHVN type run like they had a couple years ago??
0 · Reply
Galtor
Galtor Jul. 23 at 11:38 PM
$BOLD now begins the steady climb up
0 · Reply
Dirk1969
Dirk1969 Jul. 19 at 6:26 AM
$BOLD https://www.fiercebiotech.com/biotech/boundless-bio-lays-33-staff-lead-program-stumbles
1 · Reply
soopabox
soopabox Jul. 18 at 2:41 PM
$BOLD On the 3 month chart a very vague handle of a cup and handle seems to be forming. It looks more like a skillet instead of a cup. Not getting excited about it until -or- if it breaks 1.20 with volume.
1 · Reply
AceDeBase
AceDeBase Jul. 2 at 7:05 AM
$BOLD All tanks FULL. NOwhere to put ng
0 · Reply
AceDeBase
AceDeBase Jul. 2 at 6:56 AM
$BOLD SWITCH TO. TIMBER AS in. T i m b e r. Down
0 · Reply
Galtor
Galtor Jun. 29 at 12:26 AM
$BOLD way oversold now
0 · Reply
BioRich
BioRich Jun. 12 at 3:07 PM
$BOLD Loaded more to this one. Been strong on it in the past and see no reason not to be strong looking forward. Best of luck to longs believing in BOLD. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! ~BioRich Capital
2 · Reply
Zaga64
Zaga64 Jun. 11 at 4:33 PM
$BOLD Cash, cash equivalents, and short-term investments totaled $138.3 million as of March 31, 2025. Shares Outstanding 22.39M Float 14.28M
0 · Reply
Galtor
Galtor Jun. 11 at 1:08 AM
$BOLD high volume day that closes red near support. Could be the sign of a reversal.
0 · Reply
Rohtan
Rohtan Jun. 9 at 11:12 PM
$BOLD this is done for a while. May fall below $1
0 · Reply
JarvisFlow
JarvisFlow Jun. 2 at 11:00 AM
HC Wainwright & Co. has updated their rating for Boundless Bio ( $BOLD ) to Buy with a price target of 5.
0 · Reply
tradersunion353
tradersunion353 Jun. 1 at 3:47 AM
$BOLD Dilution and Reverse split coming soon
1 · Reply
buythedipsbro
buythedipsbro May. 30 at 4:25 PM
$BOLD too cheap indeed. assuming they b urn 40-50m a yr at current rate, by next year wed still have around 78-88m cash, at 25m market cap, lol
0 · Reply
Stmkr
Stmkr May. 30 at 2:02 PM
$BOLD Cash runway into 2028 $128 million cash as of Mar 2025 Trading at $25M... First 2 assets failed but now they are trying a combination of the 2 assets... Cheap for a reason. But maybe too cheap?
0 · Reply
Qtradesstocks
Qtradesstocks May. 30 at 12:17 PM
$BOLD taking an L 🥴 catalyst not expected till next year. At 50cent or so a share I’d consider buying back
0 · Reply